Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT04740580

1 development in the corpus

NCT04740580

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE EARLY PHASE 1 TRIAL

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

ClinicalTrials.gov

Early-phase uncontrolled trial (Phase 1) examining dietary supplements in Alzheimer's disease with surrogate endpoints (brain glucose uptake, inflammation) and cognition measures; no results yet reported in this registry record.

PreliminaryBaylor College of Medicine Alzheimer Disease NCT04740580

Reported

Planned enrollment52

PhaseEARLY_PHASE1

Primary outcome: Cognition assess…Day 0, 12 weeks, 24 weeks after supplementa…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support